Terms ending in 2033
Every in-force patent on Pharmajet, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,408,972 | Needle-Free Injection Device In force · High confidence | Pharmajet, Inc. | In force | High confidence | |
| US 11,471,603 | Needle-Free Injector In force · High confidence | Pharmajet Inc. | In force | High confidence | |
| US 10,322,238 | Needle-Free Intradermal Injection Device In force · Medium confidence | Pharmajet Inc. | In force | Medium confidence | |
| US 12,766,264 | Needle-Free Intradermal Injection Device In force · Medium confidence | Pharmajet Inc. | In force | Medium confidence | |
| US 11,154,659 | Needle-Free Intradermal Injection Device In force · Medium confidence | Pharmajet Inc. | In force | Medium confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.